NasdaqCM - Delayed Quote • USD
Ekso Bionics Holdings, Inc. (EKSO)
At close: 4:00 PM EDT
After hours: 4:39 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.16 | -0.13 | -0.49 | -0.24 |
Low Estimate | -0.16 | -0.13 | -0.49 | -0.24 |
High Estimate | -0.16 | -0.13 | -0.49 | -0.24 |
Year Ago EPS | -0.33 | -0.31 | -1.1 | -0.49 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 4.99M | 5.88M | 23.5M | 30.5M |
Low Estimate | 4.99M | 5.88M | 23.5M | 30.5M |
High Estimate | 4.99M | 5.88M | 23.5M | 30.5M |
Year Ago Sales | 4.12M | 4.35M | 18.28M | 23.5M |
Sales Growth (year/est) | 21.10% | 35.20% | 28.60% | 29.80% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.31 | -0.28 | -0.31 | -0.11 |
EPS Actual | -0.33 | -0.31 | -0.24 | -0.22 |
Difference | -0.02 | -0.03 | 0.07 | -0.11 |
Surprise % | -6.50% | -10.70% | 22.60% | -100.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.16 | -0.13 | -0.49 | -0.24 |
7 Days Ago | -0.16 | -0.13 | -0.49 | -0.24 |
30 Days Ago | -0.16 | -0.13 | -0.49 | -0.24 |
60 Days Ago | -0.07 | -0.05 | -0.2 | 0 |
90 Days Ago | -0.07 | -0.05 | -0.2 | 0 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | EKSO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 51.50% | -- | -- | 1.50% |
Next Qtr. | 58.10% | -- | -- | 11.40% |
Current Year | 55.50% | -- | -- | 5.20% |
Next Year | 51.00% | -- | -- | 13.40% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | HC Wainwright & Co.: Buy to Buy | 3/5/2024 |
Maintains | HC Wainwright & Co.: Buy to Buy | 1/22/2024 |
Reiterates | HC Wainwright & Co.: Buy | 4/28/2023 |
Reiterates | HC Wainwright & Co.: Buy | 3/30/2023 |
Maintains | HC Wainwright & Co.: Buy | 7/29/2022 |
Maintains | HC Wainwright & Co.: Buy | 10/30/2020 |
Related Tickers
RSMDF ResMed Inc.
17.70
0.00%
ANGO AngioDynamics, Inc.
5.87
-2.65%
STXS Stereotaxis, Inc.
2.3800
-7.03%
OCPNF Olympus Corporation
13.97
0.00%
TRUMY Terumo Corporation
17.09
+0.23%
NEPH Nephros, Inc.
2.1900
+3.79%
BLCO Bausch + Lomb Corporation
14.90
+0.34%
LMAT LeMaitre Vascular, Inc.
64.03
-0.31%
UTMD Utah Medical Products, Inc.
67.16
-0.59%
HBIO Harvard Bioscience, Inc.
3.6900
-0.81%